Combinatorial concurrent (HGF + NPC-CM) treatment and HGF-preconditioned NPC-CM demonstrated notable increases in neurite length relative to NPC-CM treatment alone (p = 0.0001, respectively; Figure 4C). The gene discussed is HGF; the disease is nasopharyngeal carcinoma.